Abstract: The present invention relates generally to methods and compositions for treating a disease or condition by administering a first therapeutic protocol comprising targeting and delivering solid-phase platelet-dependent vascular occlusion agents, and administering at least one second therapeutic composition or method.
Type:
Grant
Filed:
August 14, 2006
Date of Patent:
May 24, 2011
Assignee:
IMBiotechnologies Ltd
Inventors:
Michael W. Stewart, Antoine Noujaim, Bruce D. Hirsche, legal representative, Roland H. Person